Cucurbitacin IIb attenuates cancer cachexia induced skeletal muscle atrophy by regulating the IL ‐6/ STAT3 / FoxO signaling pathway
Phytotherapy Research · 2023-08 · 37 (8) · 3380-3393
DOI: 10.1002/ptr.7811 ↗At a glance
Journal article in Phytotherapy Research, published online on 2023-04-19. Written by Yaxian Wang and 3 co-authors. Institution: Department of Pharmacy, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Major MEDLINE topics: Cachexia, Neoplasms. Cited 20 times so far (Crossref); 48 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Natural Science Foundation of China.
Abstract (original language)
The main features of cancer cachexia include skeletal muscle atrophy, which can significantly reduce the quality of life of patients. Clinical treatment of cancer cachexia is mainly based on nutritional therapy and physical exercise; medication only improves appetite but does not reverse the symptoms of skeletal muscle wasting. In this work, we systematically studied the underlying molecular mechanisms by which cucurbitacin IIb (CuIIb) ameliorates muscle wasting in cancer cachexia both in vitro and in vivo. CuIIb significantly ameliorated the chief features of cancer cachexia in vivo, alleviating weight loss, food intake, muscle wasting, adipose tissue depletion, and organ weight reductions. In vitro, CuIIb (10 and 20 μM) dose‐dependently attenuated conditioned medium (CM)‐induced C2C12 myotube atrophy. Collectively, our findings demonstrated that CuIIb prevented the upregulation of the E3 ubiquitin ligase muscle atrophy Fbox protein (MAFbx), myosin heavy chain (MyHC), and myogenin (MyoG) and impacted protein synthesis and degradation. In addition, CuIIb decreased the phosphorylation of Tyr705 in STAT3 by regulating the IL‐6/STAT3/FoxO pathway to reduce skeletal muscle atrophy in cancer cachexia.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmacy, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
ORCID profiles: Cheng Guo
Funding
- National Natural Science Foundation of China
Cite
APA
Wang, Y., Sun, X., Yang, Q., & Guo, C. (2023). Cucurbitacin IIb attenuates cancer cachexia induced skeletal muscle atrophy by regulating the IL ‐6/ STAT3 / FoxO signaling pathway. Phytotherapy Research, 37(8), 3380-3393. https://doi.org/10.1002/ptr.7811
Vancouver
Wang Y, Sun X, Yang Q, Guo C. Cucurbitacin IIb attenuates cancer cachexia induced skeletal muscle atrophy by regulating the IL ‐6/ STAT3 / FoxO signaling pathway. Phytotherapy Research. 2023;37(8):3380-3393. doi:10.1002/ptr.7811
BibTeX
@article{Wang2023,
author = {Wang, Yaxian and Sun, Xipeng and Yang, Quanjun and Guo, Cheng},
title = {Cucurbitacin IIb attenuates cancer cachexia induced skeletal muscle atrophy by regulating the IL ‐6/ STAT3 / FoxO signaling pathway},
journal = {Phytotherapy Research},
year = {2023},
volume = {37},
number = {8},
pages = {3380--3393},
doi = {10.1002/ptr.7811}
}
EUVIMED